Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 175
Filter
Add more filters

Publication year range
1.
Cereb Cortex ; 32(16): 3525-3541, 2022 08 03.
Article in English | MEDLINE | ID: mdl-34902856

ABSTRACT

Higher-order telencephalic circuitry has been suggested to be especially vulnerable to irradiation or other developmentally toxic impact. This report details the adult effects of prenatal irradiation at a sensitive time point on clinically relevant brain functions controlled by telencephalic regions, hippocampus (HPC), and prefrontal cortex (PFC). Pregnant C57Bl6/J mice were whole-body irradiated at embryonic day 11 (start of neurogenesis) with X-ray intensities of 0.0, 0.5, or 1.0 Gy. Female offspring completed a broad test battery of HPC-/PFC-controlled tasks that included cognitive performance, fear extinction, exploratory, and depression-like behaviors. We examined neural functions that are mechanistically related to these behavioral and cognitive changes, such as hippocampal field potentials and long-term potentiation, functional brain connectivity (by resting-state functional magnetic resonance imaging), and expression of HPC vesicular neurotransmitter transporters (by immunohistochemical quantification). Prenatally exposed mice displayed several higher-order dysfunctions, such as decreased nychthemeral activity, working memory defects, delayed extinction of threat-evoked response suppression as well as indications of perseverative behavior. Electrophysiological examination indicated impaired hippocampal synaptic plasticity. Prenatal irradiation also induced cerebral hypersynchrony and increased the number of glutamatergic HPC terminals. These changes in brain connectivity and plasticity could mechanistically underlie the irradiation-induced defects in higher telencephalic functions.


Subject(s)
Prenatal Exposure Delayed Effects , Radiation Exposure , Animals , Behavior, Animal/physiology , Extinction, Psychological , Fear/psychology , Female , Hippocampus/physiology , Humans , Mice , Mice, Inbred C57BL , Neuronal Plasticity , Pregnancy , Prenatal Exposure Delayed Effects/pathology
2.
Cereb Cortex ; 29(11): 4519-4529, 2019 12 17.
Article in English | MEDLINE | ID: mdl-30590460

ABSTRACT

Learning has been proposed to coincide with changes in connections between brain regions. In the present study, we used resting-state fMRI (rsfMRI) to map brain-wide functional connectivity (FC) in mice that were trained in the hidden-platform version of the Morris water maze. C57BL6 mice were investigated in a small animal MRI scanner following 2, 10, or 15 days of acquisition learning, or 5 days of reversal learning. Spatial learning coincided with progressive and changing FC between telencephalic regions that have been implemented in spatial learning (such as hippocampus, cingulate, visual, and motor cortex). Search strategy assessment demonstrated that the use of cognitively advanced spatial strategies correlated positively with extensive telencephalic connectivity, whereas non-spatial strategies correlated negatively with connectivity. FC patterns were different and more extensive after reversal learning compared with after extended acquisition learning, which could explain why reversal learning has been shown to be more sensitive to subtle functional defects.


Subject(s)
Brain/physiology , Maze Learning/physiology , Reversal Learning/physiology , Animals , Brain Mapping , Female , Magnetic Resonance Imaging , Mice, Inbred C57BL , Spatial Processing/physiology
3.
J Neuroinflammation ; 16(1): 61, 2019 Mar 13.
Article in English | MEDLINE | ID: mdl-30866963

ABSTRACT

BACKGROUND: Microglia play a central role in most neurological disorders, but the impact of microgliosis on brain environment and clinical functions is not fully understood. Mice lacking multifunctional protein-2 (MFP2), a pivotal enzyme in peroxisomal ß-oxidation, develop a fatal disorder characterized by motor problems similar to the milder form of MFP2 deficiency in humans. The hallmark of disease in mice is the chronic proliferation of microglia in the brain, but molecular pathomechanisms that drive rapid clinical deterioration in human and mice remain unknown. In the present study, we identified the effects of specific deletion of MFP2 from microglia in the brain on immune responses, neuronal functioning, and behavior. METHODS: We created a novel Cx3cr1-Mfp2-/- mouse model and studied the impact of MFP2 deficiency on microglial behavior at different ages using immunohistochemistry and real-time PCR. Pro- and anti-inflammatory responses of Mfp2-/- microglia were assessed in vitro and in vivo after stimulation with IL-1ß/INFγ and IL-4 (in vitro) and LPS and IL-4 (in vivo). Facial nerve axotomy was unilaterally performed in Cx3cr1-Mfp2-/- and control mice, and microglial functioning in response to neuronal injury was subsequently analyzed by histology and real-time PCR. Finally, neuronal function, motor function, behavior, and cognition were assessed using brainstem auditory evoked potentials, grip strength and inverted grid test, open field exploration, and passive avoidance learning, respectively. RESULTS: We found that Mfp2-/- microglia in a genetically intact brain environment adopt an inflammatory activated and proliferative state. In addition, we found that acute inflammatory and neuronal injury provoked normal responses of Mfp2-/- microglia in Cx3cr1-Mfp2-/- mice during the post-injury period. Despite chronic pro-inflammatory microglial reactivity, Cx3cr1-Mfp2-/- mice exhibited normal neuronal transmission, clinical performance, and cognition. CONCLUSION: Our data demonstrate that MFP2 deficiency in microglia causes intrinsic dysregulation of their inflammatory profile, which is not harmful to neuronal function, motor function, and cognition in mice during their first year of life.


Subject(s)
Brain/pathology , Inflammation/pathology , Microglia/drug effects , Microglia/metabolism , Peroxisomal Multifunctional Protein-2/deficiency , Animals , Animals, Newborn , Brain/drug effects , Brain/metabolism , CX3C Chemokine Receptor 1/metabolism , Calcium-Binding Proteins/metabolism , Cell Proliferation/drug effects , Cell Proliferation/genetics , Cells, Cultured , Disease Models, Animal , Evoked Potentials, Auditory, Brain Stem/drug effects , Evoked Potentials, Auditory, Brain Stem/genetics , Exploratory Behavior/drug effects , Exploratory Behavior/physiology , Facial Nerve Diseases/complications , Facial Nerve Diseases/pathology , Functional Laterality , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Hand Strength/physiology , Inflammation/chemically induced , Interleukin-4/administration & dosage , Lipopolysaccharides/toxicity , Mice , Mice, Transgenic , Microfilament Proteins/metabolism , Microglia/pathology , Peroxisomal Multifunctional Protein-2/genetics
4.
Neurobiol Dis ; 113: 82-96, 2018 05.
Article in English | MEDLINE | ID: mdl-29427755

ABSTRACT

Type 2 diabetes (T2DM) and obesity might increase the risk for AD by 2-fold. Different attempts to model the effect of diet-induced diabetes on AD pathology in transgenic animal models, resulted in opposite conclusions. Here, we used a novel knock-in mouse model for AD, which, differently from other models, does not overexpress any proteins. Long-term high fat diet treatment triggers a reduction in hippocampal N-acetyl-aspartate/myo-inositol metabolites ratio and impairs long term potentiation in hippocampal acute slices. Interestingly, these alterations do not correlate with changes in the core neuropathological features of AD, i.e. amyloidosis and Tau hyperphosphorylation. The data suggest that AD phenotypes associated with high fat diet treatment seen in other models for AD might be exacerbated because of the overexpressing systems used to study the effects of familial AD mutations. Our work supports the increasing insight that knock-in mice might be more relevant models to study the link between metabolic disorders and AD.


Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/physiopathology , Diet, High-Fat/adverse effects , Hippocampus/metabolism , Hippocampus/physiopathology , Long-Term Potentiation/physiology , Alzheimer Disease/pathology , Animals , Blood Glucose/metabolism , Diet, High-Fat/trends , Hippocampus/pathology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Organ Culture Techniques
5.
Neurobiol Learn Mem ; 155: 113-126, 2018 11.
Article in English | MEDLINE | ID: mdl-29981423

ABSTRACT

Fear extinction is the well-known process of fear reduction through repeated re-exposure to a feared stimulus without the aversive outcome. The last two decades have witnessed a surge of interest in extinction learning. First, extinction learning is observed across species, and especially research on rodents has made great strides in characterising the physical substrate underlying extinction learning. Second, extinction learning is considered of great clinical significance since it constitutes a crucial component of exposure treatment. While effective in reducing fear responding in the short term, extinction learning can lose its grip, resulting in a return of fear (i.e., laboratory model for relapse of anxiety symptoms in patients). Optimization of extinction learning is, therefore, the subject of intense investigation. It is thought that the success of extinction learning is, at least partly, determined by the mismatch between what is expected and what actually happens (prediction error). However, while much of our knowledge about the neural circuitry of extinction learning and factors that contribute to successful extinction learning comes from animal models, translating these findings to humans has been challenging for a number of reasons. Here, we present an overview of what is known about the animal circuitry underlying extinction of fear, and the role of prediction error. In addition, we conducted a systematic literature search to evaluate the degree to which state-of-the-art neuroimaging methods have contributed to translating these findings to humans. Results show substantial overlap between networks in animals and humans at a macroscale, but current imaging techniques preclude comparisons at a smaller scale, especially in sub-cortical areas that are functionally heterogeneous. Moreover, human neuroimaging shows the involvement of numerous areas that are not typically studied in animals. Results obtained in research aimed to map the extinction circuit are largely dependent on the methods employed, not only across species, but also across human neuroimaging studies. Directions for future research are discussed.


Subject(s)
Amygdala/physiology , Brain Mapping , Conditioning, Classical/physiology , Extinction, Psychological/physiology , Fear/physiology , Hippocampus/physiology , Prefrontal Cortex/physiology , Translational Research, Biomedical , Amygdala/diagnostic imaging , Animals , Hippocampus/diagnostic imaging , Humans , Prefrontal Cortex/diagnostic imaging
6.
Neurobiol Dis ; 106: 255-268, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28720484

ABSTRACT

Alpha-mannosidosis is a glycoproteinosis caused by deficiency of lysosomal acid alpha-mannosidase (LAMAN), which markedly affects neurons of the central nervous system (CNS), and causes pathognomonic intellectual dysfunction in the clinical condition. Cognitive improvement consequently remains a major therapeutic objective in research on this devastating genetic error. Immune-tolerant LAMAN knockout mice were developed to evaluate the effects of enzyme replacement therapy (ERT) by prolonged administration of recombinant human enzyme. Biochemical evidence suggested that hippocampus may be one of the brain structures that benefits most from long-term ERT. In the present functional study, ERT was initiated in 2-month-old immune-tolerant alpha-mannosidosis mice and continued for 9months. During the course of treatment, mice were trained in the Morris water maze task to assess spatial-cognitive performance, which was related to synaptic plasticity recordings and hippocampal histopathology. Long-term ERT reduced primary substrate storage and neuroinflammation in hippocampus, and improved spatial learning after mid-term (10weeks+) and long-term (30weeks+) treatment. Long-term treatment substantially improved the spatial-cognitive abilities of alpha-mannosidosis mice, whereas the effects of mid-term treatment were more modest. Detailed analyses of spatial memory and spatial-cognitive performance indicated that even prolonged ERT did not restore higher cognitive abilities to the level of healthy mice. However, it did demonstrate marked therapeutic effects that coincided with increased synaptic connectivity, reflected by improvements in hippocampal CA3-CA1 long-term potentiation (LTP), expression of postsynaptic marker PSD-95 as well as postsynaptic density morphology. These experiments indicate that long-term ERT may hold promise, not only for the somatic defects of alpha-mannosidosis, but also to alleviate cognitive impairments of the disorder.


Subject(s)
Cognition/drug effects , Enzyme Replacement Therapy , Hippocampus/drug effects , Neuronal Plasticity/drug effects , Synapses/drug effects , alpha-Mannosidosis/drug therapy , Animals , Cognition/physiology , Disease Models, Animal , Disks Large Homolog 4 Protein/metabolism , Female , Hippocampus/pathology , Hippocampus/physiopathology , Humans , Male , Maze Learning/drug effects , Maze Learning/physiology , Mice, Knockout , Neuronal Plasticity/physiology , Recombinant Proteins/administration & dosage , Spatial Memory/drug effects , Spatial Memory/physiology , Synapses/pathology , Synapses/physiology , Time Factors , alpha-Mannosidase/administration & dosage , alpha-Mannosidase/deficiency , alpha-Mannosidase/genetics , alpha-Mannosidosis/pathology , alpha-Mannosidosis/physiopathology
7.
Biochim Biophys Acta Proteins Proteom ; 1865(7): 936-945, 2017 Jul.
Article in English | MEDLINE | ID: mdl-27760390

ABSTRACT

The Morris water maze (MWM) spatial learning task has been demonstrated to involve a cognitive switch of action control to serve the transition from an early towards a late learning phase. However, the molecular mechanisms governing this switch are largely unknown. We employed MALDI MS imaging (MSI) to screen for changes in expression of small proteins in brain structures implicated in the different learning phases. We compared mice trained for 3days and 30days in the MWM, reflecting an early and a late learning phase in relation to the acquisition of a spatial learning task. An ion with m/z of 6724, identified as PEP-19/pcp4 by top-down tandem MS, was detected at higher intensity in the dorsal striatum of the late learning phase group compared with the early learning phase group. In addition, mass spectrometric analysis of synaptosomes confirmed the presence of PEP-19/pcp4 at the synapse. PEP-19/pcp4 has previously been identified as a critical determinant of synaptic plasticity in locomotor learning. Our findings extend PEP-19/pcp4 function to spatial learning in the forebrain and put MSI forward as a valid and unbiased research strategy for the discovery and identification of the molecular machinery involved in learning, memory and synaptic plasticity. This article is part of a Special Issue entitled: MALDI Imaging, edited by Dr. Corinna Henkel and Prof. Peter Hoffmann.


Subject(s)
Nerve Tissue Proteins/metabolism , Spatial Learning/physiology , Synapses/metabolism , Synaptosomes/metabolism , Animals , Brain/metabolism , Brain/physiology , Female , Learning Disabilities/metabolism , Learning Disabilities/pathology , Locomotion/physiology , Maze Learning/physiology , Memory/physiology , Mice , Mice, Inbred C57BL , Neuronal Plasticity/physiology , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods
8.
Mol Ther ; 23(7): 1160-1168, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25896249

ABSTRACT

Metachromatic leukodystrophy (MLD) is a lysosomal storage disease caused by a functional deficiency of the lysosomal enzyme arylsulfatase A. The prevailing late-infantile variant of MLD is characterized by widespread and progressive demyelination of the central nervous system (CNS) causing death during childhood. In order to gain insight into the pathomechanism of the disease and to identify novel therapeutic targets, we analyzed neuroinflammation in two mouse models reproducing a mild, nondemyelinating, and a more severe, demyelinating, variant of MLD, respectively. Microgliosis and upregulation of cytokine/chemokine levels were clearly more pronounced in the demyelinating model. The analysis of the temporal cytokine/chemokine profiles revealed that the onset of demyelination is preceded by a sustained elevation of the macrophage inflammatory protein (MIP)-1α followed by an upregulation of MIP-1ß, monocyte chemotactic protein (MCP)-1, and several interleukins. The tumor necrosis factor (TNF)-α remains unchanged. Treatment of the demyelinating mouse model with the nonsteroidal anti-inflammatory drug simvastatin reduced neuroinflammation, improved the swimming performance and ataxic gait, and retarded demyelination of the spinal cord. Our data suggest that neuroinflammation is causative for demyelination in MLD mice and that anti-inflammatory treatment might be a novel therapeutic option to improve the CNS function of MLD patients.


Subject(s)
Central Nervous System/drug effects , Inflammation/drug therapy , Leukodystrophy, Metachromatic/drug therapy , Simvastatin/administration & dosage , Animals , Anti-Inflammatory Agents/administration & dosage , Central Nervous System/physiopathology , Chemokine CCL2/biosynthesis , Chemokine CCL4/biosynthesis , Demyelinating Diseases/drug therapy , Demyelinating Diseases/pathology , Disease Models, Animal , Humans , Inflammation/physiopathology , Leukodystrophy, Metachromatic/immunology , Mice , Spinal Cord/drug effects , Spinal Cord/pathology , Tumor Necrosis Factor-alpha/biosynthesis
9.
Proc Natl Acad Sci U S A ; 110(8): 3131-6, 2013 Feb 19.
Article in English | MEDLINE | ID: mdl-23382228

ABSTRACT

The multiple memory systems hypothesis posits that dorsal striatum and hippocampus are central nodes in independent memory systems, supporting response-based and place-based learning, respectively. Although our understanding of the function of hippocampus within this framework is relatively well established, the contribution of dorsal striatum is less clear. This in part seems to be due to the heterogeneous nature of dorsal striatum, which receives extensive topographically organized projections from higher cortical areas. Here we quantified neural activity in the intact brain while mice and humans acquired analogous versions of the Morris water maze. We found that dorsomedial striatum and medial prefrontal cortex support the initial acquisition of what is typically considered a hippocampus-dependent spatial learning task. We suggest that the circuit involving dorsomedial striatum and medial prefrontal cortex identified here plays a more task-independent role in early learning than currently thought. Furthermore, our results demonstrate that dorsomedial and dorsolateral striatum serve fundamentally different roles during place learning. The remarkably high degree of anatomical overlap in brain function between mouse and human observed in our study emphasizes the extent of convergence achievable with a well-matched multilevel approach.


Subject(s)
Corpus Striatum/physiology , Maze Learning , Prefrontal Cortex/physiology , Adult , Animals , Female , Humans , In Situ Hybridization , Mice , Mice, Inbred C57BL , Young Adult
10.
Alzheimers Dement ; 12(9): 964-976, 2016 09.
Article in English | MEDLINE | ID: mdl-27107518

ABSTRACT

INTRODUCTION: In Alzheimer's disease (AD), pathologic amyloid-beta (Aß) is synaptotoxic and impairs neuronal function at the microscale, influencing brain networks at the macroscale before Aß deposition. The latter can be detected noninvasively, in vivo, using resting-state functional MRI (rsfMRI), a technique used to assess brain functional connectivity (FC). METHODS: RsfMRI was performed longitudinally in TG2576 and PDAPP mice, starting before Aß deposition to determine the earliest FC changes. Additionally, the role of pathologic Aß on early FC alterations was investigated by treating TG2576 mice with the 3D6 anti-Aß-antibody. RESULTS: Both transgenic models showed hypersynchronized FC before Aß deposition and hyposynchronized FC at later stages. Early anti-Aß treatment in TG2576 mice prevented hypersynchronous FC and the associated synaptic impairments and excitatory/inhibitory disbalances. DISCUSSION: Hypersynchrony of FC may be used as a new noninvasive read out of early AD and can be recovered by anti-Aß treatment, encouraging preventive treatment strategies in familial AD.


Subject(s)
Alzheimer Disease/drug therapy , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/metabolism , Brain/drug effects , Brain/physiopathology , Alzheimer Disease/diagnostic imaging , Animals , Autoantibodies/pharmacology , Brain/diagnostic imaging , Brain Mapping , Cerebrovascular Circulation/physiology , Cortical Synchronization/physiology , Disease Models, Animal , Disease Progression , Longitudinal Studies , Magnetic Resonance Imaging , Mice, Transgenic , Neural Pathways/diagnostic imaging , Neural Pathways/physiopathology , Neuroprotective Agents/pharmacology , Oxygen/blood , Plaque, Amyloid/diagnostic imaging , Plaque, Amyloid/physiopathology , Plaque, Amyloid/prevention & control , Prodromal Symptoms , Rest
11.
Neurobiol Dis ; 73: 319-26, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25251606

ABSTRACT

Niemann-Pick disease type A (NPDA) is a fatal disease due to mutations in the acid sphingomyelinase (ASM) gene, which triggers the abnormal accumulation of sphingomyelin (SM) in lysosomes and the plasma membrane of mutant cells. Although the disease affects multiple organs, the impact on the brain is the most invalidating feature. The mechanisms responsible for the cognitive deficit characteristic of this condition are only partially understood. Using mice lacking the ASM gene (ASMko), a model system in NPDA research, we report here that high sphingomyelin levels in mutant neurons lead to low synaptic levels of phosphoinositide PI(4,5)P2 and reduced activity of its hydrolyzing phosphatase PLCγ, which are key players in synaptic plasticity events. In addition, mutant neurons have reduced levels of membrane-bound MARCKS, a protein required for PI(4,5)P2 membrane clustering and hydrolysis. Intracerebroventricular infusion of a peptide that mimics the effector domain of MARCKS increases the content of PI(4,5)P2 in the synaptic membrane and ameliorates behavioral abnormalities in ASMko mice.


Subject(s)
Brain/metabolism , Intracellular Signaling Peptides and Proteins/therapeutic use , Membrane Proteins/therapeutic use , Mental Disorders/drug therapy , Mental Disorders/etiology , Niemann-Pick Disease, Type A/complications , Niemann-Pick Disease, Type A/drug therapy , Animals , Avoidance Learning/drug effects , Brain/drug effects , Brain/pathology , Disease Models, Animal , Exploratory Behavior/drug effects , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Injections, Intraventricular , Lipid Metabolism/drug effects , Lipid Metabolism/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Motor Activity/drug effects , Motor Activity/genetics , Muscle Strength/drug effects , Muscle Strength/genetics , Mutation/genetics , Myristoylated Alanine-Rich C Kinase Substrate , Niemann-Pick Disease, Type A/metabolism , Niemann-Pick Disease, Type A/pathology , Phospholipase C gamma/metabolism , Sphingomyelin Phosphodiesterase/genetics , Synaptosomes/drug effects , Synaptosomes/metabolism
12.
Neurobiol Dis ; 73: 275-88, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25315682

ABSTRACT

miR-29 is expressed strongly in the brain and alterations in expression have been linked to several neurological disorders. To further explore the function of this miRNA in the brain, we generated miR-29a/b-1 knockout animals. Knockout mice develop a progressive disorder characterized by locomotor impairment and ataxia. The different members of the miR-29 family are strongly expressed in neurons of the olfactory bulb, the hippocampus and in the Purkinje cells of the cerebellum. Morphological analysis showed that Purkinje cells are smaller and display less dendritic arborisation compared to their wildtype littermates. In addition, a decreased number of parallel fibers form synapses on the Purkinje cells. We identified several mRNAs significantly up-regulated in the absence of the miR-29a/b-1 cluster. At the protein level, however, the voltage-gated potassium channel Kcnc3 (Kv3.3) was significantly up-regulated in the cerebella of the miR-29a/b knockout mice. Dysregulation of KCNC3 expression may contribute to the ataxic phenotype.


Subject(s)
Ataxia/metabolism , Cerebellum/metabolism , MicroRNAs/metabolism , Purkinje Cells/metabolism , Shaw Potassium Channels/metabolism , Animals , Behavior, Animal , Mice , Mice, Inbred C57BL , Mice, Knockout , Motor Activity
13.
Hum Brain Mapp ; 36(4): 1265-77, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25418860

ABSTRACT

Recent work has demonstrated that functional connectivity between remote brain regions can be modulated by task learning or the performance of an already well-learned task. Here, we investigated the extent to which initial learning and stable performance of a spatial navigation task modulates functional connectivity between subregions of hippocampus and striatum. Subjects actively navigated through a virtual water maze environment and used visual cues to learn the position of a fixed spatial location. Resting-state functional magnetic resonance imaging scans were collected before and after virtual water maze navigation in two scan sessions conducted 1 week apart, with a behavior-only training session in between. There was a large significant reduction in the time taken to intercept the target location during scan session 1 and a small significant reduction during the behavior-only training session. No further reduction was observed during scan session 2. This indicates that scan session 1 represented initial learning and scan session 2 represented stable performance. We observed an increase in functional connectivity between left posterior hippocampus and left dorsal caudate that was specific to scan session 1. Importantly, the magnitude of the increase in functional connectivity was correlated with offline gains in task performance. Our findings suggest cooperative interaction occurs between posterior hippocampus and dorsal caudate during awake rest following the initial phase of spatial navigation learning. Furthermore, we speculate that the increase in functional connectivity observed during awake rest after initial learning might reflect consolidation-related processing.


Subject(s)
Caudate Nucleus/physiology , Hippocampus/physiology , Maze Learning/physiology , Visual Perception/physiology , Adult , Brain Mapping , Cues , Female , Functional Laterality , Humans , Magnetic Resonance Imaging , Neural Pathways/physiology , Rest , Signal Processing, Computer-Assisted , User-Computer Interface , Water , Young Adult
14.
Int J Neuropsychopharmacol ; 18(11): pyv053, 2015 May 21.
Article in English | MEDLINE | ID: mdl-25999589

ABSTRACT

BACKGROUND: Group III metabotropic glutamate receptors (mGlu4, mGlu7, mGlu8) display differential brain distribution, which suggests different behavioral functions. However, comparison across the available animal studies remains methodologically hazardous and controversial. The present report directly compares knockouts for each group III receptor subtype using a single behavioral test battery and multivariate analysis. METHODS: The behavioral phenotypes of C57BL/6J mice lacking mGlu4, mGlu7, or mGlu8 and their respective littermates were examined using a multimetric test battery, which included elements of neuromotor performance, exploratory behavior, and learning and memory. Multivariate statistical methods were used to identify subtype-specific behavioral profiles and variables that distinguished between these mouse lines. RESULTS: It generally appears that mGlu7 plays a significant role in hippocampus-dependent spatial learning and in some fear-related behaviors, whereas mGlu4 is most clearly involved in startle and motivational processes. Excepting its influence on body weight, the effect of mGlu8 deletion on behavior appears more subtle than that of the other group III receptors. These receptors have been proposed as potential drug targets for a variety of psychopathological conditions. CONCLUSION: On the basis of these controlled comparisons, we presently conclude that the different group III receptors indeed have quite distinct behavioral functions.


Subject(s)
Learning/physiology , Memory/physiology , Motor Activity/physiology , Receptors, Metabotropic Glutamate/metabolism , Animals , Body Weight/drug effects , Body Weight/physiology , Exploratory Behavior/physiology , Fear/physiology , Female , Mice, Inbred C57BL , Mice, Knockout , Motivation/genetics , Motivation/physiology , Motor Activity/genetics , Multivariate Analysis , Receptors, Metabotropic Glutamate/genetics , Reflex, Startle/genetics , Reflex, Startle/physiology
15.
Anim Cogn ; 18(6): 1267-84, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26188712

ABSTRACT

Humans can spontaneously create rules that allow them to efficiently generalize what they have learned to novel situations. An enduring question is whether rule-based generalization is uniquely human or whether other animals can also abstract rules and apply them to novel situations. In recent years, there have been a number of high-profile claims that animals such as rats can learn rules. Most of those claims are quite weak because it is possible to demonstrate that simple associative systems (which do not learn rules) can account for the behavior in those tasks. Using a procedure that allows us to clearly distinguish feature-based from rule-based generalization (the Shanks-Darby procedure), we demonstrate that adult humans show rule-based generalization in this task, while generalization in rats and pigeons was based on featural overlap between stimuli. In brief, when learning that a stimulus made of two components ("AB") predicts a different outcome than its elements ("A" and "B"), people spontaneously abstract an opposites rule and apply it to new stimuli (e.g., knowing that "C" and "D" predict one outcome, they will predict that "CD" predicts the opposite outcome). Rats and pigeons show the reverse behavior-they generalize what they have learned, but on the basis of similarity (e.g., "CD" is similar to "C" and "D", so the same outcome is predicted for the compound stimulus as for the components). Genuinely rule-based behavior is observed in humans, but not in rats and pigeons, in the current procedure.


Subject(s)
Columbidae/physiology , Discrimination Learning , Generalization, Psychological , Rats/physiology , Animals , Association Learning , Female , Humans , Male , Pattern Recognition, Visual , Rats, Sprague-Dawley , Young Adult
16.
Proc Natl Acad Sci U S A ; 109(26): 10310-5, 2012 Jun 26.
Article in English | MEDLINE | ID: mdl-22689975

ABSTRACT

Deficiency of glycosaminoglycan (GAG) degradation causes a subclass of lysosomal storage disorders called mucopolysaccharidoses (MPSs), many of which present with severe neuropathology. Critical steps in the degradation of the GAG heparan sulfate remain enigmatic. Here we show that the lysosomal arylsulfatase G (ARSG) is the long-sought glucosamine-3-O-sulfatase required to complete the degradation of heparan sulfate. Arsg-deficient mice accumulate heparan sulfate in visceral organs and the central nervous system and develop neuronal cell death and behavioral deficits. This accumulated heparan sulfate exhibits unique nonreducing end structures with terminal N-sulfoglucosamine-3-O-sulfate residues, allowing diagnosis of the disorder. Recombinant human ARSG is able to cleave 3-O-sulfate groups from these residues as well as from an authentic 3-O-sulfated N-sulfoglucosamine standard. Our results demonstrate the key role of ARSG in heparan sulfate degradation and strongly suggest that ARSG deficiency represents a unique, as yet unknown form of MPS, which we term MPS IIIE.


Subject(s)
Arylsulfatases/antagonists & inhibitors , Mucopolysaccharidoses/etiology , Sulfatases/metabolism , Animals , Behavior, Animal , Mice , Mucopolysaccharidoses/enzymology
17.
J Neurosci ; 33(32): 12915-28, 12928a, 2013 Aug 07.
Article in English | MEDLINE | ID: mdl-23926248

ABSTRACT

The metalloproteinase ADAM10 is of importance for Notch-dependent cortical brain development. The protease is tightly linked with α-secretase activity toward the amyloid precursor protein (APP) substrate. Increasing ADAM10 activity is suggested as a therapy to prevent the production of the neurotoxic amyloid ß (Aß) peptide in Alzheimer's disease. To investigate the function of ADAM10 in postnatal brain, we generated Adam10 conditional knock-out (A10cKO) mice using a CaMKIIα-Cre deleter strain. The lack of ADAM10 protein expression was evident in the brain cortex leading to a reduced generation of sAPPα and increased levels of sAPPß and endogenous Aß peptides. The A10cKO mice are characterized by weight loss and increased mortality after weaning associated with seizures. Behavioral comparison of adult mice revealed that the loss of ADAM10 in the A10cKO mice resulted in decreased neuromotor abilities and reduced learning performance, which were associated with altered in vivo network activities in the hippocampal CA1 region and impaired synaptic function. Histological and ultrastructural analysis of ADAM10-depleted brain revealed astrogliosis, microglia activation, and impaired number and altered morphology of postsynaptic spine structures. A defect in spine morphology was further supported by a reduction of the expression of NMDA receptors subunit 2A and 2B. The reduced shedding of essential postsynaptic cell adhesion proteins such as N-Cadherin, Nectin-1, and APP may explain the postsynaptic defects and the impaired learning, altered network activity, and synaptic plasticity of the A10cKO mice. Our study reveals that ADAM10 is instrumental for synaptic and neuronal network function in the adult murine brain.


Subject(s)
ADAM Proteins/deficiency , Amyloid Precursor Protein Secretases/deficiency , Brain/ultrastructure , Dendritic Spines/pathology , Epilepsy/genetics , Epilepsy/pathology , Learning Disabilities/pathology , Membrane Proteins/deficiency , Synapses/pathology , ADAM10 Protein , Amyloid beta-Protein Precursor/metabolism , Animals , Animals, Newborn , Brain/pathology , Cadherins/metabolism , Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics , Cell Adhesion Molecules/metabolism , Dendritic Spines/metabolism , Disease Models, Animal , Gene Expression Regulation, Developmental/genetics , Gliosis/genetics , Learning Disabilities/genetics , Mice , Mice, Transgenic , Nectins , Receptors, N-Methyl-D-Aspartate/metabolism , Synapses/metabolism , Synapses/ultrastructure
18.
Hum Mol Genet ; 21(11): 2599-609, 2012 Jun 01.
Article in English | MEDLINE | ID: mdl-22388935

ABSTRACT

Metachromatic leukodystrophy (MLD) is a lysosomal storage disease caused by a functional deficiency of arylsulfatase A (ASA). Previous studies in ASA-knockout mice suggested enzyme replacement therapy (ERT) to be a promising treatment option. The mild phenotype of ASA-knockout mice did, however, not allow to examine therapeutic responses of the severe neurological symptoms that dominate MLD. We, therefore, generated an aggravated MLD mouse model displaying progressive demyelination and reduced nerve conduction velocity (NCV) and treated it by weekly intravenous injections of 20 mg/kg recombinant human ASA for 16 weeks. To analyze the stage-dependent therapeutic effects, ERT was initiated in a presymptomatic, early and progressed disease stage, at age 4, 8 and 12 months, respectively. Brain sulfatide storage, NCV and behavioral alterations were improved only in early, but not in late, treated mice showing a clear age-dependent efficacy of treatment. Hematopoietic stem cell transplantation (HSCT) for late-onset variants is the only therapeutic option for MLD to date. ERT resembles a part of the HSCT rationale, which is based on ASA supply by donor cells. Beyond ERT, our results, therefore, corroborate the clinical observation that HSCT is only effective when performed in early stages of disease.


Subject(s)
Leukodystrophy, Metachromatic/genetics , Leukodystrophy, Metachromatic/therapy , Animals , CHO Cells , Cerebroside-Sulfatase/genetics , Cerebroside-Sulfatase/metabolism , Cricetinae , Disease Models, Animal , Enzyme Replacement Therapy , Genetic Therapy , Mice , Mice, Knockout , Transfection , Treatment Outcome
19.
EMBO J ; 29(8): 1318-30, 2010 Apr 21.
Article in English | MEDLINE | ID: mdl-20203623

ABSTRACT

Synaptic vesicle recycling involves AP-2/clathrin-mediated endocytosis, but it is not known whether the endosomal pathway is also required. Mice deficient in the tissue-specific AP-1-sigma1B complex have impaired synaptic vesicle recycling in hippocampal synapses. The ubiquitously expressed AP-1-sigma1A complex mediates protein sorting between the trans-Golgi network and early endosomes. Vertebrates express three sigma1 subunit isoforms: A, B and C. The expressions of sigma1A and sigma1B are highest in the brain. Synaptic vesicle reformation in cultured neurons from sigma1B-deficient mice is reduced upon stimulation, and large endosomal intermediates accumulate. The sigma1B-deficient mice have reduced motor coordination and severely impaired long-term spatial memory. These data reveal a molecular mechanism for a severe human X-chromosome-linked mental retardation.


Subject(s)
Adaptor Protein Complex 1/metabolism , Endosomes/metabolism , Learning , Memory , Synaptic Vesicles/metabolism , Adaptor Protein Complex 1/analysis , Adaptor Protein Complex 1/genetics , Animals , Behavior, Animal , Cells, Cultured , Clathrin/metabolism , Female , Gene Expression , Hippocampus/cytology , Humans , Mice , Mice, Knockout , Motor Activity , Neurons/metabolism , Protein Isoforms/analysis , Protein Isoforms/genetics , Protein Isoforms/metabolism
20.
EMBO J ; 29(19): 3408-20, 2010 Oct 06.
Article in English | MEDLINE | ID: mdl-20818335

ABSTRACT

The amyloid peptides Aß(40) and Aß(42) of Alzheimer's disease are thought to contribute differentially to the disease process. Although Aß(42) seems more pathogenic than Aß(40), the reason for this is not well understood. We show here that small alterations in the Aß(42):Aß(40) ratio dramatically affect the biophysical and biological properties of the Aß mixtures reflected in their aggregation kinetics, the morphology of the resulting amyloid fibrils and synaptic function tested in vitro and in vivo. A minor increase in the Aß(42):Aß(40) ratio stabilizes toxic oligomeric species with intermediate conformations. The initial toxic impact of these Aß species is synaptic in nature, but this can spread into the cells leading to neuronal cell death. The fact that the relative ratio of Aß peptides is more crucial than the absolute amounts of peptides for the induction of neurotoxic conformations has important implications for anti-amyloid therapy. Our work also suggests the dynamic nature of the equilibrium between toxic and non-toxic intermediates.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/toxicity , Neurons/metabolism , Peptide Fragments/toxicity , Plaque, Amyloid/metabolism , Amyloid beta-Peptides/metabolism , Amyloid beta-Peptides/ultrastructure , Analysis of Variance , Animals , Benzothiazoles , Biophysics , Fluorescent Dyes , Humans , Kinetics , Mice , Microelectrodes , Microscopy, Electron, Transmission , Patch-Clamp Techniques , Peptide Fragments/metabolism , Peptide Fragments/ultrastructure , Protein Binding , Spectroscopy, Fourier Transform Infrared , Thiazoles
SELECTION OF CITATIONS
SEARCH DETAIL